Low serum bilirubin concentration is associated with coronary artery calcification (CAC)

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 287-291

  Tanaka, Muhei ^a,b   Fukui, Michiaki ^a   Tomiyasu, Ki ichiro ^b   Akabame, Satoshi ^b   Nakano, Koji ^b   Hasegawa, Goji ^a   Oda, Yohei ^a   Nakamura, Naoto ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Yamashiro Public Hospital   (Japan)

Author keywords

Atherosclerosis; Bilirubin; CAC

Indexed keywords

ANTIHYPERTENSIVE AGENT; BILIRUBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL LABORATORY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BILIRUBIN; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 69049096003     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.010     Document Type: Article

References (27)

1. Stocker R., Yamamoto Y., McDonagh A., Glazer A.N., and Ames N.B. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
2. Baranano D.E., Rao M., Ferris C.D., and Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U.S.A. 99 (2002) 16093-16098
3. Vítek L., Jirsa M., Brodanová M., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160 (2002) 449-456
4. Erdogan D., Gullu H., Yildirim E., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184 (2006) 431-437
5. Perlstein T.S., Pande R.L., Beckman J.A., and Creager M.A. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 28 (2008) 166-172
6. Vítek L., Novotný L., Sperl M., Holaj R., and Spácil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 21 (2006) 408-414
7. Baumgart D., Schmermund A., Goerge G., et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J Am Coll Cardiol 30 (1997) 57-64
8. Nallamothu B.K., Saint S., Bielak L.F., et al. Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. Arch Intern Med 161 (2001) 833-838
9. Rumberger J.A., Brundage B.H., Rader D.J., and Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74 (1999) 243-252
10. Budoff M.J., Achenbach S., Blumenthal R.S., et al. American Heart Association Committee on Cardiovascular Imaging and Intervention; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 (2006) 1761-1791
11. Tanaka M, Tomiyasu K, Fukui M, et al. Evaluation of characteristics and degree of remodeling in coronary atherosclerotic lesions by 64-detector multislice computed tomography (MSCT). Atherosclerosis; in press.
12. Akabame S., Hamaguchi M., Tomiyasu K., et al. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J 72 (2008) 618-625
13. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
14. Levey A.S., Stevens L.A., and Hostetter T. Automatic reporting of estimated glomerular filtration rate-just what the doctor ordered. Clin Chem 52 (2006) 2188-2193
15. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
16. Novotný L., and Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 228 (2003) 568-571
17. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98 (1993) 1-9
18. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993) 1007-1011
19. Frankel E.N., Kanner J., German J.B., Parks E., and Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341 (1993) 454-457
20. Ishizaka N., Ishizaka Y., Takahashi E., Yamakado M., and Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 32 (2001) 580-583
21. Folsom A.R., Kronmal R.A., Detrano R.C., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 168 (2008) 1333-1339
22. Schwertner H.A. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136 (1998) 383-387
23. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr 53 (1991) 1050S-1055S
24. Kushi L.H., Folsom A.R., Prineas R.J., et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334 (1996) 1156-1162
25. Knekt P., Ritz J., Pereira M.A., et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80 (2004) 1508-1520
26. Sesso H.D., Buring J.E., Christen W.G., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300 (2008) 2123-2133
27. Nanditha B., and Prabhasankar P. Antioxidants in bakery products: a review. Crit Rev Food Sci Nutr 49 (2009) 1-27